June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Retrospective study of clinical results in patients diagnosed with pars planitis treated with via pars plana vitrectomy
Author Affiliations & Notes
  • Gustavo Vela
    Fundación Hospital Nuestra Señora de la Luz, Mexico City, Mexico
  • Stephanie Voorduin
    Fundación Hospital Nuestra Señora de la Luz, Mexico City, Mexico
  • Footnotes
    Commercial Relationships Gustavo Vela, None; Stephanie Voorduin, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2544. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gustavo Vela, Stephanie Voorduin; Retrospective study of clinical results in patients diagnosed with pars planitis treated with via pars plana vitrectomy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2544. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To retrospectively analyze the clinical results of patients diagnosed with pars planitis at the Nuestra Señora de la Luz Hospital, specifically of those which underwent via pars plana vitrectomy.

Methods: We made a retrospective and observational study of clinical histories of 20 patients which underwent vitrectomy at the Nuestra Señora de la Luz Hospital between the years 2007 and 2012.

Results: From the 20 patients 15 were male and 5 female. Their ages went from 4 to 17. None of the patients had undergone surgery before. All of them had received paraocular or systemic corticosteroids, and 19/23 (eyes) were treated with immunomodulators. The most common surgery indication was cataract. Sixty percent of the surgeries were performed within twelve months of the diagnosis. The average time the patients were followed was 29 months. Sixty five percent of the patients had an improved visual acuity after the procedure. Sixty percent of the patients required no additional treatment after the procedure. Only five eyes had intraoperative complications, fourty four percent had postsurgical complications.

Conclusions: Vitrectomy is a safe and efficient therapeutic option for the treatment of pars planitis. It has been traditionally used for complicated cases that do not respond to medical treatment (glucocorticoids and immunomodulators). The results in this study support the fact that vitrectomy should be considered an early treatment and not always the last option in the treatment algorithm.

Keywords: 432 autoimmune disease • 745 uvea • 763 vitreous  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×